Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Double-Blind, Randomized, Parallel-Group, Active- and Placebo-Controlled Polysomnography Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Subjects With Insomnia Disorder

Next Previous
X
Search
Trial Profile

A Multicenter, Double-Blind, Randomized, Parallel-Group, Active- and Placebo-Controlled Polysomnography Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Subjects With Insomnia Disorder

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 09 Feb 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Seltorexant (Primary) ; Zolpidem
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Janssen Pharmaceutical KK; Janssen Research & Development; Janssen-Cilag; Minerva Neurosciences

    • Most Recent Events

    • 24 Jun 2019 Results presented in a Minerva Neurosciences media release.
    • 24 Jun 2019 Primary endpoint has been met. (Change from Baseline in Latency to Persistent Sleep (LPS) as Measured by Polysomnography (PSG) on Night 1), according to a Minerva Neurosciences media release.
    • 23 Jun 2019 According to the Minerva Neurosciences media release, company will host a live conference call and webcast on June 24, 2019 at 8:30 a.m. Eastern Time to discuss the results of this study. To access the webcast please go to https://engage.vevent.com/rt/minervaneurosciencesinc~062419.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top